# Nelarabine

NDC: 70710-1726
Generic name: Nelarabine
Labeler / Manufacturer: Zydus Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20211117

FDA application: ANDA215037

## Active ingredients

- NELARABINE: 5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70710-1726"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70710-1726
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e425731e-626b-4141-a997-fb85e077c2a4